HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 1,189-1,200 of 2,276
Drug study icon
CompletedACTRN12608000461392

study of a Selective Estrogen Receptor Modulator (raloxifene) in Schizophrenia

Official study title

Clinical Trial of a Selective Estrogen Receptor Modulator (raloxifene) in the treatment of cognitive deficits and psychotic symptoms of patients with schizophrenia

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaInterventional studyAges 18–55
Countries
Australia
Sponsor
University of New South Wales
Drug study icon
CompletedNCT04846868

study of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

What is this study about?

Researchers compared Iclepertin and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaMedication studyAges 18–50
Countries
Australia, United States, Canada, + 14 others
Sponsor
Boehringer Ingelheim
Drug study icon
CompletedACTRN12619000575134

Study of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in people with Major Depressive Disorder

Official study title

A Phase 2 Clinical Trial of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in Participants with Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
Praxis Precision Medicines Australia, Pty Ltd
Drug study icon
TerminatedACTRN12621001539820

Clozapine Obesity and Semaglutide Treatment (COaST). A controlled multi-centre study of semaglutide versus placebo for people with schizophrenia on clozapine with obesity

Official study title

Clozapine Obesity and Semaglutide Treatment (COaST). A randomised controlled multi-centre trial of semaglutide versus placebo for people with schizophrenia on clozapine with obesity

This study ended early.

In Australia
SchizophreniaInterventional studyAges 18–64
Countries
Australia
Sponsor
The University of Queensland
Behavioral study icon
CompletedACTRN12613000402741

Cluster controlled study of a psycho-educational intervention for people with a family history of depression for use in general practice

Official study title

A cluster randomised controlled trial comparing the efficacy of a targeted psycho-education intervention about depression to usual care in people with a family history of depression. The LINKS study.

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
University of New South Wales

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.